{"doi":"10.1007\/s11239-009-0383-6","coreId":"195766","oai":"oai:lra.le.ac.uk:2381\/7879","identifiers":["oai:lra.le.ac.uk:2381\/7879","10.1007\/s11239-009-0383-6"],"title":"Tissue plasminogen activator antigen predicts medium-term left ventricular end-systolic volume after acute myocardial infarction","authors":["Weir, R.A.","Balmain, S.","Steedman, T.","Ng, L.L.","Squire, I.B.","Rumley, A.","Dargie, H.J.","Lowe, G.D."],"enrichments":{"references":[],"documentType":{"type":null}},"contributors":[],"datePublished":"2009-08","abstract":"Metadata. \\ud\nFull text of this item is not currently available on the LRA.Von Willebrand factor (VWF) and tissue plasminogen activator (t-PA) predict adverse cardiovascular outcome following acute myocardial infarction (AMI) and are weakly associated with pre-discharge left ventricular ejection fraction (LVEF). We examined the relationships between VWF, t-PA antigen, matrix metalloproteinase (MMP)-2,-3, and -9, and B-type natriuretic peptide (BNP), and their predictive effect on serial change in LV volumes in a cohort of patients admitted with AMI. Plasma VWF, t-PA antigen, MMP-2,-3,-9, and BNP were measured at a mean 46 h after AMI in 100 patients (mean age 58.9 \u00b1 12 years, 77% male) with depressed LVEF. Cardiac magnetic resonance (CMR) imaging was then performed. Biomarker measurement and CMR were repeated at 12 and 24 weeks. Plasma concentrations of VWF, BNP and MMP-9 were elevated while t-PA antigen concentration was at the upper limits of normal; over 24 weeks VWF, t-PA antigen, MMP-9 and BNP decreased significantly. Baseline VWF correlated with BNP (r = 0.35, P < 0.001) and MMP-3 (r = 0.24, P = 0.019) as did t-PA antigen (r = 0.27, P = 0.007 for BNP; r = 0.40, P < 0.001 for MMP-3). t-PA antigen, VWF, MMP-3 and BNP were univariate predictors of LV end-systolic volume at 24 weeks; tPA antigen and BNP remained significant independent predictors on multivariate analysis. t-PA antigen and VWF are related to medium-term LV volumes after AMI, and to MMP-3. This novel link between the coagulation-fibrinolysis system and matrix turnover merits further study in understanding the pathophysiology of adverse ventricular remodeling after AMI","downloadUrl":"","fullTextIdentifier":null,"pdfHashValue":null,"publisher":"Springer Verlag","rawRecordXml":"<record><header><identifier>\n        \n            \n                oai:lra.le.ac.uk:2381\/7879<\/identifier><datestamp>\n                2010-07-08T11:37:46Z<\/datestamp><setSpec>\n                com_2381_10<\/setSpec><setSpec>\n                com_2381_9550<\/setSpec><setSpec>\n                col_2381_11<\/setSpec>\n            <\/header><metadata><oai_dc:dc xmlns:oai_dc=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/\" xmlns:dc=\"http:\/\/purl.org\/dc\/elements\/1.1\/\" xmlns:doc=\"http:\/\/www.lyncode.com\/xoai\" xmlns:xsi=\"http:\/\/www.w3.org\/2001\/XMLSchema-instance\" xsi:schemaLocation=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/ http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc.xsd\" ><dc:title>\n            \nTissue plasminogen activator antigen predicts medium-term left ventricular end-systolic volume after acute myocardial infarction<\/dc:title><dc:creator>\nWeir, R.A.<\/dc:creator><dc:creator>\nBalmain, S.<\/dc:creator><dc:creator>\nSteedman, T.<\/dc:creator><dc:creator>\nNg, L.L.<\/dc:creator><dc:creator>\nSquire, I.B.<\/dc:creator><dc:creator>\nRumley, A.<\/dc:creator><dc:creator>\nDargie, H.J.<\/dc:creator><dc:creator>\nLowe, G.D.<\/dc:creator><dc:subject>\nTissue plasminogen activator antigen<\/dc:subject><dc:subject>\nVon Willebrand factor<\/dc:subject><dc:subject>\nMyocardial infarction<\/dc:subject><dc:subject>\nCardiac magnetic resonance<\/dc:subject><dc:description>\nMetadata. \\ud\nFull text of this item is not currently available on the LRA.<\/dc:description><dc:description>\nVon Willebrand factor (VWF) and tissue plasminogen activator (t-PA) predict adverse cardiovascular outcome following acute myocardial infarction (AMI) and are weakly associated with pre-discharge left ventricular ejection fraction (LVEF). We examined the relationships between VWF, t-PA antigen, matrix metalloproteinase (MMP)-2,-3, and -9, and B-type natriuretic peptide (BNP), and their predictive effect on serial change in LV volumes in a cohort of patients admitted with AMI. Plasma VWF, t-PA antigen, MMP-2,-3,-9, and BNP were measured at a mean 46 h after AMI in 100 patients (mean age 58.9 \u00b1 12 years, 77% male) with depressed LVEF. Cardiac magnetic resonance (CMR) imaging was then performed. Biomarker measurement and CMR were repeated at 12 and 24 weeks. Plasma concentrations of VWF, BNP and MMP-9 were elevated while t-PA antigen concentration was at the upper limits of normal; over 24 weeks VWF, t-PA antigen, MMP-9 and BNP decreased significantly. Baseline VWF correlated with BNP (r = 0.35, P < 0.001) and MMP-3 (r = 0.24, P = 0.019) as did t-PA antigen (r = 0.27, P = 0.007 for BNP; r = 0.40, P < 0.001 for MMP-3). t-PA antigen, VWF, MMP-3 and BNP were univariate predictors of LV end-systolic volume at 24 weeks; tPA antigen and BNP remained significant independent predictors on multivariate analysis. t-PA antigen and VWF are related to medium-term LV volumes after AMI, and to MMP-3. This novel link between the coagulation-fibrinolysis system and matrix turnover merits further study in understanding the pathophysiology of adverse ventricular remodeling after AMI.<\/dc:description><dc:date>\n2010-05-07T09:44:36Z<\/dc:date><dc:date>\n2010-05-07T09:44:36Z<\/dc:date><dc:date>\n2009-08<\/dc:date><dc:type>\nArticle<\/dc:type><dc:identifier>\nJ Thromb Thrombolysis. DOI 10.1007\/s11239-009-0383-6. Tissue plasminogen activator antigen predicts medium-term left ventricular end-systolic volume after acute myocardial infarction<\/dc:identifier><dc:identifier>\n0929-5305 (Print)<\/dc:identifier><dc:identifier>\n1573-742X (Online)<\/dc:identifier><dc:identifier>\nhttp:\/\/dx.doi.org\/10.1007\/s11239-009-0383-6<\/dc:identifier><dc:identifier>\nhttp:\/\/hdl.handle.net\/2381\/7879<\/dc:identifier><dc:language>\nen<\/dc:language><dc:format>\nMetadata<\/dc:format><dc:publisher>\nSpringer Verlag<\/dc:publisher>\n<\/oai_dc:dc>\n<\/metadata>\n        <\/record>","journals":null,"language":null,"relations":[],"year":2009,"topics":["Tissue plasminogen activator antigen","Von Willebrand factor","Myocardial infarction","Cardiac magnetic resonance"],"subject":["Article"],"fullText":null}